NCT02603809: A reported trial by Idorsia Pharmaceuticals Ltd.
This trial has reported on time, in line with the regulations.
Full data
Full entry on ClinicalTrials.gov | NCT02603809 |
---|---|
Title | A Multi-center, Double-blind, Double-dummy, Randomized, Placebo- and Active-reference, Parallel Group, Phase 2, Dose-finding Study With ACT-132577 in Subjects With Essential Hypertension (Grade 1 and 2). |
Results Status | Reported |
ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
Start date | Dec. 14, 2015 |
Completion date | Feb. 28, 2017 |
Required reporting date | Feb. 28, 2020, midnight |
Actual reporting date | Feb. 27, 2020 |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | None |